Searched for
OLAPARIB TABLETS
Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in ChinaIndian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health mi...12 Nov, 2025, 07.03 AM IST- AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drugAstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) 100mg and...15 Apr, 2025, 01.48 PM IST
- AstraZeneca Pharma gets CSDCO nod to import anti-cancer drug LynparzaAstraZeneca Pharma India has received regulatory approval to import and distribute Lynparza (Olaparib) tablets in 100mg and 150mg doses. Th...26 Nov, 2024, 03.00 PM IST
- DCGI orders withdrawal of cancer drug Olaparib for certain treatmentsThe Drug Controller General of India has requested the withdrawal of AstraZeneca's Olaparib tablets for certain cancer treatments due to po...23 May, 2024, 12.29 AM IST
- Regulator asks state bodies to limit scope of key cancer drugIndia's drug regulatory authority has instructed state-level counterparts to mandate manufacturers of Olaparib tablets in 100 mg and 150 mg...22 May, 2024, 01.41 AM IST
- Natco Pharma submits application with USFDA for generic cancer drugThe company has submitted an Abbreviated New Drug Application (ANDA) containing a 'paragraph IV' certification with the US Food and Drug Ad...13 Feb, 2023, 02.56 PM IST
- Jet Airways, TCS and Persistent Systems among top stocks to track todayHere's a look at the top stocks that may hog the limelight in Friday's session.17 Aug, 2018, 08.25 AM IST
Load More
